CSI Market
Sign In | Register

Enanta Pharmaceuticals Inc (ENTA) Annual Income Statement

Annual · GAAP · USD millions
Access ENTA quarterly income statements →
The data below summarizes Enanta Pharmaceuticals Inc's income statement results from Sep 30 2021 to Sep 30 2025, enabling period-by-period comparison of operating performance.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Sep 30 2025)
2025 		(Sep 30 2024) (Sep 30 2023) (Sep 30 2022) (Sep 30 2021)
Revenues
Revenue From Contract With Customer Excluding Assessed Tax65.32
Total Revenue65.32
Costs & Expenses
Gross Profit65.32
Selling, Administration, Marketing43.93
Research and Development Expense106.74
Other Operating Expense / -Income0.00
Total operating costs including COS150.67
Operating income / -loss-85.35
Interest Expense0.00
Net Interest (-)Expense / Income0.00
Other loss / -income-1.80
Total costs & expenses148.87
Income & Taxes
Income / -loss before income taxes-83.55
Income taxes expenses / -benefit-1.66
Income after income taxes-81.89
Net income / -loss of other equity0.00
Income / -loss from continuing operations-81.89
Net income / -loss-81.89
Income / -loss to shareholder-81.89
EBIT-83.55
EBITD-76.23
EBITDA-76.23
Earnings Per Share
Basic EPS (excl. extra items)-3.84
Basic Net EPS-3.84
Basic shares outstanding (Mill. of Units)21.34
Diluted Net EPS-3.84
Diluted average shares (Mill. of Units)21.34
4 historic quarters locked

Sign in to unlock the full Enanta Pharmaceuticals Inc income statement history.

Sign In Create Free Account

About Enanta Pharmaceuticals Inc Annual Income Statement

What this statement shows

This page presents issuer-reported income statement data, detailing revenue, operating costs, expenses, and earnings as disclosed in SEC 10-K filings and standardized by CSIMarket. The income statement reflects operating performance over a reporting period rather than financial position at a single date.

Revenue and expense treatment

Revenue and expense items are aligned to support period-to-period comparability. Operating and non-operating items, interest, and income taxes are classified based on issuer disclosures and XBRL tagging.

Source & verification

  • Source: SEC 10-K filings
  • Filed with the SEC: November 19, 2025
  • Original filing: enta-20250930.htm

Income statement figures represent operating results for each reporting period and may be revised in subsequent filings.